866-997-4948(US-Canada Toll Free)

Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 285 Pages

 

Global Pneumococcal Vaccines Market: Overview

This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global pneumococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, distribution channel, sector, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pneumococcal vaccines market.

Global Pneumococcal Vaccines Market: Key Segments

Based on product type, the global pneumococcal vaccines market has been segmented into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of these segments is categorized into pediatric and adults. In terms of distribution channel, the global market has been classified into wholesalers (pharmacy channel), specialized companies, public authorities, and others. Based on sector, the market has been bifurcated into private and public. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pneumococcal Vaccines Market: Regional Outlook

In terms of region, the global pneumococcal vaccines market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Belgium, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World (Middle East and Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.

The global pneumococcal vaccines market has been segmented as below:

Global Pneumococcal Vaccines Market, by Product Type

  • Synflorix
    • Pediatric
    • Adult
  • Prevenar-13
    • Pediatric
    • Adult
  • PCV 13 (pipeline)
  • Pediatric
  • Adult
  • V114 (Merck)
    • Pediatric
    • Adult
  • PCV-20 (Pfizer)
    • Pediatric
    • Adult
  • PCV-10 (SII)
    • Pediatric
    • Adult
  • PPSV- 23
    • Pediatric
    • Adult
  • Global Pneumococcal Vaccines Market, by Distribution Channel
    • Wholesalers (pharmacy channel)
    • Specialized Companies
    • Public Authorities
    • Others
  • Global Pneumococcal Vaccines Market, by Sector
    • Public
    • Private
  • Global Pneumococcal Vaccines Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Italy
  • France
  • Spain
  • Belgium
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Rest of the World
  • Middle East
  • Africa

1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

2. Assumptions and Research Methodology 
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Pneumococcal Vaccines Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Pneumococcal Vaccines Market: Market Snapshot, 2016

4. Market Overview
4.1. Overview
4.2. Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast, 2016–2026
4.3. Global Pneumococcal Vaccines Market Outlook
4.4. Approved & Pipeline Products Snapshot

5. Market Dynamics
5.1. Drivers 
5.1.1. Government participation in design & implementation of comprehensive vaccination programs
5.1.2. Increase in investments by public & private players in R&D of conjugate pneumococcal vaccines
5.2. Restraints
5.2.1. Longer timeline and high cost associated with development of pneumococcal vaccines
5.3. Opportunities
5.3.1. Development of multivalent conjugated vaccines with different serotypes
5.4. Trends
5.4.1. Public-Private Partnerships

6. Global Pneumococcal Vaccines Market Analysis, by Product Type
6.1. Introduction
6.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Product Type
6.3. Pneumococcal Vaccines Market Analysis, by Product Type 
6.3.1. Synflorix
6.3.1.1. Pediatric
6.3.1.2. Adult
6.3.2. Prevenar-13
6.3.2.1. Pediatric
6.3.2.2. Adult
6.3.3. PCV 13 (pipeline)
6.3.3.1. Pediatric
6.3.3.2. Adult
6.3.4. V114 (Merck)
6.3.4.1. Pediatric
6.3.4.2. Adult
6.3.5. PCV-20 (Pfizer)
6.3.5.1. Pediatric
6.3.5.2. Adult
6.3.6. PCV-10 (SII)
6.3.6.1. Pediatric
6.3.6.2. Adult
6.3.7. PPSV- 23
6.3.7.1. Pediatric
6.3.7.2. Adult

7. Global Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.1. Introduction
7.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
7.3. Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.3.1. Wholesalers
7.3.2. Specialized Companies 
7.3.3. Public Authorities 
7.3.4. Others

8. Global Pneumococcal Vaccines Market Analysis, by Sector
8.1. Introduction
8.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Sector
8.3. Pneumococcal Vaccines Market Analysis, by Sector
8.3.1. Public
8.3.2. Private

9. U.S. Pneumococcal Vaccines Market Analysis
9.1. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
9.2. U.S. Pneumococcal Vaccines Market Forecast, by Product Type
9.2.1. Prevanar-13
9.2.2. V114
9.2.3. PCV-20
9.2.4. Pneumovax-23
9.3. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
9.4. U.S. Pneumococcal Vaccines Market Forecast, by Distribution Channel
9.4.1. Wholesalers
9.4.2. Specialized Companies 
9.4.3. Public Authorities 
9.4.4. Others 
9.5. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Sector
9.6. U.S. Pneumococcal Vaccines Market Forecast, by Sector
9.6.1. Private
9.6.2. Public
10. Canada Pneumococcal Vaccines Market Analysis

10.1. Canada Pneumococcal Vaccines Market Value Share Analysis, by Product Type
10.2. Canada Pneumococcal Vaccines Market Forecast, by Product Type
10.2.1. Prevenar-13
10.2.2. Synflorix 
10.2.3. V-114 
10.2.4. Pneumo - 23
10.2.5. Pnuemovax-23
10.3. Canada Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
10.4. Canada Pneumococcal Vaccines Market Forecast, by Distribution Channel
10.4.1. Wholesalers
10.4.2. Specialized Companies 
10.4.3. Public Authorities 
10.4.4. Others 
10.5. Canada Pneumococcal Vaccines Market Value Share Analysis, by Sector
10.6. Canada Pneumococcal Vaccines Market Forecast, by Sector
10.6.1. Private
10.6.2. Public

11. Germany Pneumococcal Vaccines Market Analysis
11.1. Germany Pneumococcal Vaccines Market Value Share Analysis, by Product Type
11.2. Germany Pneumococcal Vaccines Market Forecast, by Product Type
11.2.1. Prevenar-13
11.2.2. Synflorix 
11.2.3. V-114 
11.2.4. PCV-20
11.2.5. Pnuemovax-23
11.3. Germany Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
11.4. Germany Pneumococcal Vaccines Market Forecast, by Distribution Channel
11.4.1. Wholesalers
11.4.2. Specialized Companies 
11.4.3. Public Authorities 
11.4.4. Others 
11.5. Germany Pneumococcal Vaccines Market Value Share Analysis, by Sector
11.6. Germany Pneumococcal Vaccines Market Forecast, by Sector
11.6.1. Private
11.6.2. Public

12. U.K. Pneumococcal Vaccines Market Analysis
12.1. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
12.2. U.K. Pneumococcal Vaccines Market Forecast, by Product Type
12.2.1. Prevenar-13
12.2.2. Synflorix 
12.2.3. V-114 
12.2.4. PCV-20
12.2.5. Pnuemovax-23
12.3. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
12.4. U.K. Pneumococcal Vaccines Market Forecast, by Distribution Channel
12.4.1. Wholesalers
12.4.2. Specialized Companies 
12.4.3. Public Authorities 
12.4.4. Others 
12.5. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Sector
12.6. U.K. Pneumococcal Vaccines Market Forecast, by Sector
12.6.1. Private
12.6.2. Public

13. France Pneumococcal Vaccines Market Analysis
13.1. France Pneumococcal Vaccines Market Value Share Analysis, by Product Type
13.2. France Pneumococcal Vaccines Market Forecast, by Product Type
13.2.1. Prevenar-13
13.2.2. Synflorix 
13.2.3. V-114 
13.2.4. PCV-20
13.2.5. Pnuemovax-23
13.3. France Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
13.4. France Pneumococcal Vaccines Market Forecast, by Distribution Channel
13.4.1. Wholesalers
13.4.2. Specialized Companies 
13.4.3. Public Authorities 
13.4.4. Others 
13.5. France Pneumococcal Vaccines Market Value Share Analysis, by Sector
13.6. France Pneumococcal Vaccines Market Forecast, by Sector
13.6.1. Private
13.6.2. Public

14. Italy Pneumococcal Vaccines Market Analysis
14.1. Italy Pneumococcal Vaccines Market Value Share Analysis, by Product Type
14.2. Italy Pneumococcal Vaccines Market Forecast, by Product Type
14.2.1. Prevenar-13
14.2.2. Synflorix 
14.2.3. V-114 
14.2.4. PCV-20
14.2.5. Pnuemovax-23
14.3. Italy Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
14.4. Italy Pneumococcal Vaccines Market Forecast, by Distribution Channel
14.4.1. Wholesalers
14.4.2. Specialized Companies 
14.4.3. Public Authorities 
14.4.4. Others 
14.5. Italy Pneumococcal Vaccines Market Value Share Analysis, by Sector
14.6. Italy Pneumococcal Vaccines Market Forecast, by Sector
14.6.1. Private
14.6.2. Public

15. Spain Pneumococcal Vaccines Market Analysis
15.1. Spain Pneumococcal Vaccines Market Value Share Analysis, by Product Type
15.2. Spain Pneumococcal Vaccines Market Forecast, by Product Type
15.2.1. Prevenar-13
15.2.2. Synflorix 
15.2.3. V-114 
15.2.4. PCV-20
15.2.5. Pnuemovax-23
15.3. Spain Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
15.4. Spain Pneumococcal Vaccines Market Forecast, by Distribution Channel
15.4.1. Wholesalers
15.4.2. Specialized Companies 
15.4.3. Public Authorities 
15.4.4. Others 
15.5. Spain Pneumococcal Vaccines Market Value Share Analysis, by Sector
15.6. Spain Pneumococcal Vaccines Market Forecast, by Sector
15.6.1. Private
15.6.2. Public

16. Belgium Pneumococcal Vaccines Market Analysis
16.1. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Product Type
16.2. Belgium Pneumococcal Vaccines Market Forecast, by Product Type
16.2.1. Prevenar-13
16.2.2. Synflorix 
16.2.3. V-114 
16.2.4. PCV-20
16.2.5. Pnuemovax-23
16.3. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
16.4. Belgium Pneumococcal Vaccines Market Forecast, by Distribution Channel
16.4.1. Wholesalers
16.4.2. Specialized Companies 
16.4.3. Public Authorities 
16.4.4. Others 
16.5. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Sector
16.6. Belgium Pneumococcal Vaccines Market Forecast, by Sector
16.6.1. Private
16.6.2. Public

17. India Pneumococcal Vaccines Market Analysis
17.1. India Pneumococcal Vaccines Market Value Share Analysis, by Product Type
17.2. India Pneumococcal Vaccines Market Forecast, by Product Type
17.2.1. Prevenar-13
17.2.2. Synflorix 
17.2.3. SIIL PCV-10
17.2.4. PCV-20
17.2.5. Pnuemovax-23
17.3. India Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
17.4. India Pneumococcal Vaccines Market Forecast, by Distribution Channel
17.4.1. Wholesalers
17.4.2. Specialized Companies 
17.4.3. Public Authorities 
17.4.4. Others 
17.5. India Pneumococcal Vaccines Market Value Share Analysis, by Sector
17.6. India Pneumococcal Vaccines Market Forecast, by Sector
17.6.1. Private
17.6.2. Public
18. China Pneumococcal Vaccines Market Analysis
18.1. China Pneumococcal Vaccines Market Value Share Analysis, by Product Type
18.2. China Pneumococcal Vaccines Market Forecast, by Product Type
18.2.1. Prevenar-13
18.2.2. PCV 13 (pipeline)
18.2.3. PPSV 23
18.3. China Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
18.4. China Pneumococcal Vaccines Market Forecast, by Distribution Channel
18.4.1. Wholesalers
18.4.2. Specialized Companies 
18.4.3. Public Authorities 
18.4.4. Others 
18.5. China Pneumococcal Vaccines Market Value Share Analysis, by Sector
18.6. China Pneumococcal Vaccines Market Forecast, by Sector
18.6.1. Private
18.6.2. Public

19. Japan Pneumococcal Vaccines Market Analysis
19.1. Japan Pneumococcal Vaccines Market Value Share Analysis, by Product Type
19.2. Japan Pneumococcal Vaccines Market Forecast, by Product Type
19.2.1. Prevenar-13
19.2.2. Synflorix
19.2.3. PPSV 23
19.3. Japan Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
19.4. Japan Pneumococcal Vaccines Market Forecast, by Distribution Channel
19.4.1. Wholesalers
19.4.2. Specialized Companies 
19.4.3. Public Authorities 
19.4.4. Others 
19.5. Japan Pneumococcal Vaccines Market Value Share Analysis, by Sector
19.6. Japan Pneumococcal Vaccines Market Forecast, by Sector
19.6.1. Private
19.6.2. Public

20. Australia Pneumococcal Vaccines Market Analysis
20.1. Australia Pneumococcal Vaccines Market Value Share Analysis, by Product Type
20.2. Australia Pneumococcal Vaccines Market Forecast, by Product Type
20.2.1. Prevenar-13
20.2.2. Synflorix
20.2.3. V114
20.2.4. Pnuemovax-23
20.3. Australia Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
20.4. Australia Pneumococcal Vaccines Market Forecast, by Distribution Channel
20.4.1. Wholesalers
20.4.2. Specialized Companies 
20.4.3. Public Authorities 
20.4.4. Others 
20.5. Australia Pneumococcal Vaccines Market Value Share Analysis, by Sector
20.6. Australia Pneumococcal Vaccines Market Forecast, by Sector
20.6.1. Private
20.6.2. Public

21. New Zealand Pneumococcal Vaccines Market Analysis
21.1. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Product Type
21.2. New Zealand Pneumococcal Vaccines Market Forecast, by Product Type
21.2.1. Prevenar-13
21.2.2. Synflorix
21.2.3. Pnuemovax-23
21.3. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
21.4. New Zealand Pneumococcal Vaccines Market Forecast, by Distribution Channel
21.4.1. Wholesalers
21.4.2. Specialized Companies 
21.4.3. Public Authorities 
21.4.4. Others 
21.5. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Sector
21.6. New Zealand Pneumococcal Vaccines Market Forecast, by Sector
21.6.1. Private
21.6.2. Public

22. Brazil Pneumococcal Vaccines Market Analysis
22.1. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Product Type
22.2. Brazil Pneumococcal Vaccines Market Forecast, by Product Type
22.2.1. Prevenar-13
22.2.2. Synflorix
22.2.3. Pnuemovax-23
22.3. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
22.4. Brazil Pneumococcal Vaccines Market Forecast, by Distribution Channel
22.4.1. Wholesalers
22.4.2. Specialized Companies 
22.4.3. Public Authorities 
22.4.4. Others 
22.5. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Sector
22.6. Brazil Pneumococcal Vaccines Market Forecast, by Sector
22.6.1. Private
22.6.2. Public

23. Mexico Pneumococcal Vaccines Market Analysis
23.1. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Product Type
23.2. Mexico Pneumococcal Vaccines Market Forecast, by Product Type
23.2.1. Prevenar-13
23.2.2. Synflorix
23.2.3. Pnuemovax-23
23.3. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
23.4. Mexico Pneumococcal Vaccines Market Forecast, by Distribution Channel
23.4.1. Wholesalers
23.4.2. Specialized Companies 
23.4.3. Public Authorities 
23.4.4. Others 
23.5. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Sector
23.6. Mexico Pneumococcal Vaccines Market Forecast, by Sector
23.6.1. Private
23.6.2. Public

24. Rest of the World Pneumococcal Vaccines Market Analysis
24.1. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Product Type
24.2. Rest of the World Pneumococcal Vaccines Market Forecast, by Product Type
24.2.1. Prevenar-13
24.2.2. Synflorix
24.2.3. V-114
24.2.4. PCV-20
24.2.5. PCV-10 (SII)
24.2.6. Pnuemovax-23
24.3. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
24.4. Rest of the World Pneumococcal Vaccines Market Forecast, by Distribution Channel
24.4.1. Wholesalers
24.4.2. Specialized Companies 
24.4.3. Public Authorities 
24.4.4. Others 
24.5. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Sector
24.6. Rest of the World Pneumococcal Vaccines Market Forecast, by Sector
24.6.1. Private
24.6.2. Public
24.7. Rest of the World Pneumococcal Vaccines Market Forecast, by Region

25. Competition Landscape
25.1. Global Pneumococcal Vaccines Market Share Analysis, by Company (2017)
25.2. Company Profiles
25.2.1. Pfizer, Inc.
25.2.2. Merck & Co., Inc.
25.2.3. SK Chemicals
25.2.4. Serum Institute of India Pvt. Ltd.
25.2.5. Chengdu Institute of Biological Products Co., Ltd.
25.2.6. GlaxoSmithKline plc
25.2.7. Sanofi
25.2.8. Walvax Biotechnology Co., Ltd.

List of Table

TABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 4 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 5 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 6 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 7 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 8 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 9 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 10 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 11 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 12 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 13 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 14 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 15 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 16 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 17 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 18 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 19 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 20 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 21 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 22 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 23 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 24 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 25 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 26 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 27 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 28 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 29 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 30 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 31 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 32 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 33 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 34 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 35 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 36 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 37 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 38 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 39 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 40 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 41 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 42 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 43 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 44 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 45 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 46 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 47 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 48 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 49 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 50 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 51 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 52 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 53 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 54 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 55 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 56 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 57 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 58 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 59 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 60 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 61 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 62 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 63 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 64 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 65 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 68 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Region, 2016–2026
TABLE 69 North America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country, 2016–2026
TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 71 Asia Pacific Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 72 Latin America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Chart

FIG. 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2016–2026
FIG. 2 Global Pneumococcal Vaccines Market Value Share (%), by Product Type (2017)
FIG. 3 Global Pneumococcal Vaccines Market Value Share (%), by Sector (2017)
FIG. 4 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel (2017)
FIG. 5 Global Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 6 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent, 2016–2026
FIG. 7 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent (pipeline), 2016–2026
FIG. 8 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent, 2016–2026
FIG. 9 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent (pipeline), 2016–2026
FIG. 10 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 15-Valent (pipeline), 2016–2026
FIG. 11 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 20-Valent (pipeline), 2016–2026
FIG. 12 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 23-Valent, 2016–2026
FIG. 13 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 14 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Wholesalers, 2016–2026
FIG. 15 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialized Companies, 2016–2026
FIG. 16 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public Authorities, 2016–2026
FIG. 17 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
FIG. 18 Global Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 19 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public, 2016–2026
FIG. 20 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Private, 2016–2026
FIG. 21 U.S. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 22 U.S. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 23 U.S. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 24 Canada Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 25 Canada Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 26 Canada Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 27 Germany Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 28 Germany Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 29 Germany Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 30 U.K. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 31 U.K. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 32 U.K. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 33 France Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 34 France Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 35 France Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 36 Italy Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 37 Italy Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 38 Italy Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 39 Spain Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 40 Spain Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 41 Spain Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 42 Belgium Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 43 Belgium Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 44 Belgium Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 45 India Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 46 India Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 47 India Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 48 China Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 49 China Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 50 China Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 51 Japan Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 52 Japan Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 53 Japan Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 54 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 55 Australia Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 56 Australia Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 57 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 58 New Zealand Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 59 New Zealand Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 60 Brazil Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 61 Brazil Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 62 Brazil Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 63 Mexico Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 64 Mexico Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 65 Mexico Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
FIG. 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
FIG. 68 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
FIG. 69 Global Pneumococcal Vaccines Market Share (%) and Market Share Range (%), by Company, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *